0.7922
price down icon3.40%   -0.0279
after-market Handel nachbörslich: .79 -0.0022 -0.28%
loading
Schlusskurs vom Vortag:
$0.8201
Offen:
$0.844
24-Stunden-Volumen:
1.09M
Relative Volume:
1.44
Marktkapitalisierung:
$231.83M
Einnahmen:
$6.23M
Nettoeinkommen (Verlust:
$-95.90M
KGV:
5.2813
EPS:
0.15
Netto-Cashflow:
$-68.47M
1W Leistung:
-20.78%
1M Leistung:
-16.88%
6M Leistung:
-42.59%
1J Leistung:
-32.86%
1-Tages-Spanne:
Value
$0.79
$0.8499
1-Wochen-Bereich:
Value
$0.7811
$1.00
52-Wochen-Spanne:
Value
$0.7811
$1.93

Precigen Inc Stock (PGEN) Company Profile

Name
Firmenname
Precigen Inc
Name
Telefon
301-556-9900
Name
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Mitarbeiter
202
Name
Twitter
@precigen
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PGEN's Discussions on Twitter

Vergleichen Sie PGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
PGEN 0.7922 231.83M 6.23M -95.90M -68.47M 0.15
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-05-23 Eingeleitet JP Morgan Neutral
2022-11-18 Eingeleitet Cantor Fitzgerald Overweight
2021-02-25 Eingeleitet Stifel Buy
2021-02-22 Eingeleitet Wells Fargo Overweight
2021-02-18 Eingeleitet B. Riley Securities Buy
2020-05-08 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Precigen Inc Aktie (PGEN) Neueste Nachrichten

pulisher
04:08 AM

HC Wainwright Reduces Earnings Estimates for Precigen - MarketBeat

04:08 AM
pulisher
Nov 15, 2024

PGEN stock touches 52-week low at $0.78 amid market challenges - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

HC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Precigen Inc. (PGEN) Quarterly 10-Q Report - Quartz

Nov 15, 2024
pulisher
Nov 14, 2024

Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Precigen Inc (PGEN) Q3 2024 Earnings: EPS Misses at $(0.09), Rev - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Precigen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Precigen Reports Third Quarter 2024 Financial Results and Business Updates - Quantisnow

Nov 14, 2024
pulisher
Nov 14, 2024

Precigen (NASDAQ:PGEN) Shares Cross Below 200 Day Moving AverageHere's Why - MarketBeat

Nov 14, 2024
pulisher
Nov 12, 2024

Precigen CEO to Present at Stifel 2024 Healthcare Conference: Gene Therapy Innovation Spotlight | PGEN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 09, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World

Nov 09, 2024
pulisher
Nov 06, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Target Price from Analysts - MarketBeat

Nov 06, 2024
pulisher
Nov 02, 2024

PGEN (Precigen) EBITDA per Share : $-0.52 (TTM As of Jun. 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

Precigen Announces Pricing of $30.0 Million Public Offering of C - GuruFocus.com

Nov 02, 2024
pulisher
Oct 31, 2024

Iridian Asset Management LLC CT Grows Stock Position in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

PGEN stock touches 52-week low at $0.82 amid market challenges - Investing.com Australia

Oct 30, 2024
pulisher
Oct 29, 2024

Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th - GuruFocus.com

Oct 29, 2024
pulisher
Oct 24, 2024

High Growth Tech Stocks To Watch In October 2024 - Simply Wall St

Oct 24, 2024
pulisher
Oct 18, 2024

Should you Hold Precigen (PGEN)? - Insider Monkey

Oct 18, 2024
pulisher
Oct 12, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 12, 2024
pulisher
Oct 11, 2024

A company insider recently bought 58,823 shares of Precigen Inc [PGEN]. Should You Buy? - Knox Daily

Oct 11, 2024
pulisher
Oct 11, 2024

Precigen reclaims rights after terminating license agreement By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 11, 2024

Precigen Inc (PGEN) stock analysis: A simple moving average approach - US Post News

Oct 11, 2024
pulisher
Oct 11, 2024

Precigen reclaims rights after terminating license agreement - Investing.com India

Oct 11, 2024
pulisher
Oct 10, 2024

Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch

Oct 10, 2024
pulisher
Oct 10, 2024

Precigen Regains Full Control of Technology Post Agreement Termination - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Precigen : Termination of Material Agreement Form 8 K - Marketscreener.com

Oct 10, 2024
pulisher
Oct 08, 2024

Upward Trajectory: Precigen Inc (PGEN) Posts a Slidee, Closing at 0.85 - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

When Will Precigen, Inc. (NASDAQ:PGEN) Turn A Profit? - Simply Wall St

Oct 08, 2024
pulisher
Oct 07, 2024

PGEN’s latest rating updates from top analysts. - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Is Precigen Inc (PGEN) positioned for future growth? - SETE News

Oct 07, 2024
pulisher
Oct 03, 2024

SVP, IP Affairs Perez Jeffrey Thomas acquire 58,823 shares of Precigen Inc [PGEN] - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

Precigen (NASDAQ:PGEN) Shares Cross Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Oct 03, 2024
pulisher
Oct 01, 2024

How to interpret Precigen Inc (PGEN)’s stock chart patterns - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io

Oct 01, 2024
pulisher
Sep 30, 2024

Financial Analysis: Precigen Inc (PGEN)’s Ratios Unveil Key Insights - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Precigen Inc (PGEN) receives an Underweight rating from JP Morgan - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

Precigen's SWOT analysis: biotech firm's stock rides on PRGN-2012 success - Investing.com

Sep 30, 2024
pulisher
Sep 24, 2024

Precigen Inc (PGEN)’s stock performance: a year in review - US Post News

Sep 24, 2024
pulisher
Sep 23, 2024

Biotech Co. Precigen Announces IP Exec's Departure - Law360

Sep 23, 2024
pulisher
Sep 23, 2024

Precigen Inc (PGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Precigen senior VP Jeffrey Perez quits - Investing.com

Sep 23, 2024
pulisher
Sep 22, 2024

J.P. Morgan cuts Precigen to underweight, cites burn rate - MSN

Sep 22, 2024
pulisher
Sep 19, 2024

Precigen Inc Inc. (PGEN) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

Precigen Inc [NASDAQ: PGEN] Sees Increase in Stock Value - Knox Daily

Sep 19, 2024
pulisher
Sep 18, 2024

What is Precigen Inc (PGEN) Stock Return on Shareholders’ Capital? - SETE News

Sep 18, 2024
pulisher
Sep 17, 2024

Investing in Precigen Inc (PGEN): What You Must Know - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

The Precigen Inc (PGEN) had a good session last reading, didn’t it? - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Precigen Inc’s Market Journey: Closing Weak at 1.00, Down -4.78 - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

Analysts Set Precigen, Inc. (NASDAQ:PGEN) Target Price at $7.00 - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Principal Financial Group Inc. Sells 37,802 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

Sep 17, 2024

Finanzdaten der Precigen Inc-Aktie (PGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):